tirzepatide dosing weight loss Conversion chart for for Zepbound (Tirzepatide) Dosage Guide for

The SUSTAIN-6 trial showed a significant reduction in major adverse cardiovascular events (MACE), including non-fatal myocardial infarction and non-fatal stroke, specifically in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors

Instead of the normal liquid state of the blood, it turns into a semi-solid state

"Unlike GLP-1 receptor agonists, these supplements do not carry the same risks of hypoglycemia or more serious effects like pancreatitis or gallbladder issues

However, menstrual irregularities have been reported anecdotally by some women using the medication, especially those experiencing significant weight loss